Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by First Hospital of Jilin University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Yanhua Ding, First Hospital of Jilin University
ClinicalTrials.gov Identifier:
NCT01605513
First received: May 10, 2012
Last updated: May 23, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)